High Quality Growth Stocks: How to Screen for Compounders

The best investments in stock market history share two characteristics — and we've built our screening framework around both: exceptional business quality and sustained growth. Companies like Visa, Costco, and Microsoft didn't deliver decades of shareholder wealth through cheap valuations — they did it by compounding earnings at high rates, year after year, protected by competitive moats that kept competitors at bay.

Screening for these compounders requires combining quality metrics with growth metrics — and then having the discipline to pay a fair price. The biggest mistake growth investors make isn't buying growth stocks; it's overpaying for them. The second biggest mistake value investors make is avoiding them entirely because they never look "cheap" on traditional valuation metrics.

What Defines a Quality Growth Stock

A quality growth stock meets four criteria simultaneously. First, high returns on capital: ROIC above 15% sustained for five or more years. This indicates the business has structural advantages that allow it to earn well above its cost of capital. Second, consistent earnings growth: revenue and earnings per share growing at 10%+ annually for five years. Not one-off spikes — consistent, sustainable expansion.

Third, a durable competitive moat: the growth must be protected by switching costs, network effects, intangible assets, cost advantages, or efficient scale. Growth without a moat is temporary — competitors will enter and compete away the returns. Fourth, strong cash conversion: free cash flow should track or exceed reported earnings. Growth funded by accounting tricks rather than genuine cash generation is an illusion.

The Compounder Screen

A practical screen for quality compounders: ROIC above 15% averaged over five years, revenue growth above 10% annually over three years, free cash flow positive and growing, moat rating of Wide or Narrow, gross margin above 40% (indicating pricing power), and debt-to-equity below 1.0.

For valuation, use price-to-fair-value below 1.3 rather than traditional P/E thresholds. Compounders rarely trade at low P/E ratios because the market correctly assigns premium valuations to durable growth. The question isn't whether the P/E is low — it's whether the price is reasonable relative to what the business is actually worth.

The Compounding Math

Why quality growth investing works: a business earning 20% ROIC that retains and reinvests 70% of earnings is growing intrinsic value at 14% annually. Even if you pay a fair price — no discount — your expected return is approximately the rate of intrinsic value growth. At 14% compounding, your investment doubles in roughly five years and grows eightfold in fifteen years.

This is why Buffett evolved from buying mediocre businesses at deep discounts (Graham's approach) to buying wonderful businesses at fair prices (Munger's influence). The compounding math of a high-ROIC, growing business is so powerful that the entry price matters less than the durability of the competitive advantage. A 10% premium to fair value costs you a fraction of a year's compounding — trivial over a decade-long holding period.

Where to Find Compounders

Compounders cluster in sectors where competitive advantages are durable: technology (network effects, switching costs), healthcare (patents, regulatory barriers), consumer brands (intangible assets, customer loyalty), and financial services (data advantages, switching costs). They're rare in commoditized industries where returns on capital are structurally low.

The most efficient way to find them is a tool that evaluates quality, moat durability, and valuation simultaneously — then lets you see which stocks in the universe sit in the high-quality, reasonably-valued zone that compounders occupy. This is exactly what the quality-versus-valuation framework was designed for.